India Glycols scheduled September 2, 2026, as the effective date for its NCLT-approved demerger. The company will spin off its spirits, biofuel, and biopharma businesses into separate entities. The core chemical business will remain with India Glycols.
Shareholders will receive one share of IGL Spirits Limited for every share currently held. Investors will also receive one share of Ennature Bio Pharma Ltd for every three shares held.
This strategic move aims to unlock value by creating focused pure-play companies. Analysts have expressed a positive outlook on the restructuring.